quantisnow
FeedTopReportsPricing
⌘K
Live feed
21:54:48·71d
SECFiling
Pilgrim's Pride Corporation logo

Pilgrim's Pride Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

PPC· Pilgrim's Pride Corporation
Consumer Staples
Original source

Companies

  • PPC
    Pilgrim's Pride Corporation
    Consumer Staples

Recent analyst ratings

  • Jun 23UpdateGoldman$50.00
  • Oct 3UpdateStephens$43.00
  • Aug 15UpdateBofA Securities$47.00
  • Aug 12UpdateBMO Capital Markets$46.00
  • Jun 18UpdateArgus$41.00
  • Apr 16UpdateBarclays$38.00

Related

  • PR10d
    Pilgrim's Pride Corporation Announces Pricing of Tender Offer for Its 6.250% Senior Notes Due 2033
  • PR13d
    Pilgrim's Pride Corporation Announces Early Tender Results for up to $250 Million Aggregate Principal Amount of Its Outstanding 6.250% Senior Notes Due 2033
  • PR15d
    Pilgrim's Pride Corporation to Host First Quarter Earnings Call on April 30, 2026
  • PR25d
    Pilgrim's Pride Corporation Announces Cash Tender Offer for Up to $250 Million Aggregate Principal Amount of its Outstanding 6.250% Senior Notes Due 2033
  • INSIDER50d
    President and CEO Sandri Fabio was granted 30,181 shares and converted options into 6,740 shares, increasing direct ownership by 13% to 327,851 units (SEC Form 4)
  • INSIDER50d
    Chief Financial Officer Galvanoni Matthew R converted options into 3,609 shares, sold $303,016 worth of shares (6,963 units at $43.52) and was granted 15,694 shares, increasing direct ownership by 16% to 91,397 units (SEC Form 4)
  • PR63d
    Just Bare® Delivers $1 Billion in Annual Retail Sales as Pilgrim's Accelerates Momentum in Prepared Foods
  • SEC64d
    SEC Form 144 filed by Pilgrim's Pride Corporation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022